Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
about
Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and UsesNanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluationTopical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.Capsaicin-loaded nanolipoidal carriers for topical application: design, characterization, and in vitro/in vivo evaluation.(31)P solid-state NMR based monitoring of permeation of cell penetrating peptides into skin.Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.Systemic Administration of siRNA via cRGD-containing Peptide.Cyclic Dipeptide Shuttles as a Novel Skin Penetration Enhancement Approach: Preliminary Evaluation with DiclofenacDermal microdialysis technique to evaluate the trafficking of surface-modified lipid nanoparticles upon topical application.Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma.Preparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticlesUltra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention.Cell-penetrating peptides as a novel transdermal drug delivery system.Therapeutic potential of cell-penetrating peptides.Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis.Nanomedicine strategies for targeting skin inflammation.Stratum corneum modulation by chemical enhancers and lipid nanostructures: implications for transdermal drug delivery.Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers.Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels.Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.Functionalised nanostructures for transdermal delivery of drug cargos.Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.Effect of combination of hydrophilic and lipophilic permeation enhancers on the skin permeation of kahalalide F.Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis.How can lipid nanocarriers improve transdermal delivery of olanzapine?Engineering nanoparticles to overcome barriers to immunotherapy.Basic considerations in the dermatokinetics of topical formulationsDeepened cellular/subcellular interface penetration and enhanced antitumor efficacy of cyclic peptidic ligand-decorated accelerating active targeted nanomedicines
P2860
Q28071773-80672245-333D-4E33-8EC7-CA48E3C978ECQ28542908-7FCD2C9D-7A78-4EBF-8008-440079E6923BQ30432272-E454184F-A037-4264-8667-10DCCB08C350Q33734460-05444157-0663-4175-9DD2-A687D271BB59Q34736361-48CB8847-A0E0-4401-B786-823AC8F34D12Q35772168-40898FDD-D7FE-4105-9249-2B2DD5FEE7A9Q35989535-3F7DE0C1-ED07-4B1A-9943-5700F568AA7BQ36109341-179E5FBA-D540-4BEB-B846-85CC6730661CQ36176209-B9CC927D-E589-473C-B8C2-B282DF3A77AEQ36641553-FFD4244B-58A1-49A1-807E-C3F30B7EB417Q37134733-405D972C-E1CC-4D9C-81D9-40E7FD349260Q37141351-8DE0BFD7-628B-4869-96BD-48983D65CC2BQ37727325-6A36F245-0271-46E9-9769-F49B1B3AC9DFQ38030731-F729751E-83B6-479D-B684-1002B783E49AQ38104407-86B75649-99CB-4A68-A149-595B69B6252FQ38195310-5614E379-2D92-4011-90BE-D9A4FCCD2464Q38260735-0BDEF4F9-4439-4446-A244-A26DE4DBFCFAQ39450103-6BCAD5A1-78F4-480A-829B-A43563AB2D00Q42731716-458DBEF3-B430-4EFF-80A6-44D63988ADB1Q47098090-83289D11-5CBD-434C-8655-40B8DCAC42A8Q47444826-A7256569-60FB-4B8A-997C-75A8DDC836CEQ47738254-8237C325-A0A5-4F13-A792-D04CD2F0F803Q50072089-DD0D30E1-07DB-442C-AE4A-C7D17CC035DEQ53092152-928CFEA7-6BF9-40F6-AF8C-83DA9A75FF2DQ53655387-29B96402-493A-48A9-9146-50DA1CFEDB9DQ53667150-6498391D-039B-4C8A-8596-62D687064FC9Q54991276-285F3A62-AFE5-47C0-8094-B63E227341D7Q56035513-C18B71C8-8F33-4987-B4DE-D5339480C2CAQ57073301-7A11B4BF-CCEF-44F7-9D01-72563C10AB76
P2860
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
@ast
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
@en
type
label
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
@ast
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
@en
prefLabel
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
@ast
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
@en
P2093
P2860
P1476
Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
@en
P2093
Debra Channer
Mandip Singh
Pinaki R Desai
Punit P Shah
P2860
P304
P356
10.1016/J.JCONREL.2012.05.011
P407
P577
2012-05-14T00:00:00Z